P

Protalix Biotherapiutics

175 employees

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Therapeutics
Manufacturing

Date founded

1994

Funding rounds raised

Total raised

$44M

from 7 investors over 7 rounds

P

Protalix Biotherapiutics raised $40M on February 11, 2021

Investors: Cybele Holdings

P

Protalix Biotherapiutics raised $44M on March 12, 2020

Investors: Alrov Group and Highbridge Capital Management

P

Protalix Biotherapiutics raised $6M on March 10, 2009

Investors: MATIMOP - The Israeli Industry Center for R&D

P

Protalix Biotherapiutics raised $4M on April 8, 2008

Investors: MATIMOP - The Israeli Industry Center for R&D

P

Protalix Biotherapiutics raised $5.3M on December 25, 2005

Investors: DOCOR and Tamares Real Estate Holdings, Inc

FAQ